Get started
Author

Nastaran Khodakarim

Observed names: Khodakarim, Nastaran, N. Khodakarim, Nastaran Khodakarim, Nastaran khodakarim
Observed institutions: Pasteur Institute of Iran, Iran University of Medical Sciences, University of Tehran, Rasool Akram Hospital, Shahid Beheshti University, Shahid Beheshti University of Medical Sciences
ORCID: 0000-0002-2123-9956
Observed ORCID: 0000-0002-2123-9956
OpenAlex ID: A5055938376
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study
2020 · Hassan Abolghasemi, Peyman Eshghi, et al. · Transfusion and Apheresis Science · 188
PDF
In vitro and in vivo anti-malarial activity of Boerhavia elegans and Solanum surattense
2010 · Ali Ramazani, Sedigheh Zakeri, et al. · Malaria Journal · 100
PDF
Unusual complication of aluminum phosphide poisoning: Development of hemolysis and methemoglobinemia and its successful treatment
2011 · Kambiz Soltaninejad, Leiws S. Nelson, et al. · Indian Journal of Critical Care Medicine · 33
Nanodrug-based modulation of platelet–leukocyte interactions in ovarian cancer: a new frontier in targeted therapy
2025 · Jalal Naghinezhad, Somayeh Moradpanah, et al. · Cancer Nanotechnology · 23
PDF
A comparative study to assess the effectiveness of curcumin, mucosamin, and chlorhexidine in chemotherapy-induced oral mucositis
2022 · Farshid Fardad, Katayoon Ghasemi, et al. · EXPLORE · 15
Dengue virus infection: how platelet-leukocyte crosstalk shapes thrombotic events and inflammation
2025 · Arash Amin, Farahnaz Nikdoust, et al. · Molecular Biology Reports · 11
Prevalence and molecular identification of protozoan intestinal parasitic infections in cancer patients and a control group
2024 · Leyla Bahadorizadeh, Khadijeh Khanaliha, et al. · BMC Infectious Diseases · 11
PDF
Fasting mimicking diet during neo-adjuvant chemotherapy in breast cancer patients: a randomized controlled trial study
2024 · Alireza Bahrami, Shirin Haghighi, et al. · Frontiers in Nutrition · 9
PDF
When GPVI Goes Rogue: Pathogenesis and Therapeutic Horizons in ITP
2026 · Jalal Naghinezhad, Ahmad Mohajerian, et al. · Expert Reviews in Molecular Medicine · 8
The Unseen Enemies: Harnessing the Role of Neutrophil Extracellular Traps in Breast Cancer Progression, Immune Evasion, and Treatment Resistance
2025 · Somayeh Moradpanah, Shabnam Forouzin, et al. · Clinical Breast Cancer · 4
The Role of Long Noncoding RNAs (LncRNAs) in the Pathogenesis of Chemoresistance in Endometrial Cancer: A Molecular Approach and Future Perspective
2024 · Khadijeh Lorestani, Mahsa Esgandari, et al. · Indian Journal of Gynecologic Oncology · 4
Simultaneous bilateral pulmonary and cardiac invasion of metastatic testicular germ cell tumor: A rare case report
2023 · Taghi Riahi, Mahboubeh Pazoki, et al. · Sonography · 3
Comparative Utility of 68Ga-FAPI PET/CT and 18F-FDG PET/CT in Assessing Treatment Response in a Case of Metastatic Anal Melanoma With Brain Involvement
2025 · Ghasemali Divband, Masoume Chehrara, et al. · Clinical Nuclear Medicine · 1
Interactions Between Platelets and Leukocytes in Ovarian Cancer: A New Approach to Cancer Treatment: A Review
2025 · Somayeh Moradpanah, Amineh Arab Khazael Mahabadi, et al. · Indian Journal of Gynecologic Oncology · 1
Comparison of Efficacy and safety of Tinapeg® vs. Neulastim® to prevent chemotherapy-induced neutropenia in breast cancer patients: randomized, parallel, equivalence, multicentric and Phase III clinical trial study
2023 · Seied Asadollah Mousavi, Nazli Servatian, et al. · Research Square · 1
PDF
Effect of Convalescent Plasma Therapy on COVID-19 Patients: A Retrospective Study
2023 · Mahboobeh Shojaei, Saeid Shahrabi, et al. · Jundishapur Journal of Chronic Disease Care · 1
PDF
Effectiveness of Plasmapheresis Treatment in the Treatment of Patients with COVID-19 Disease
2022 · Nastaran Khodakarim, Saeed Kalantari, et al. · Medical Journal of the Islamic Republic of Iran · 1
PDF
Evaluation of Progression-Free Survival and Overall Survival of Epidermal Growth Factor Receptor-Positive Metastatic Lung Adenocarcinoma Patients Treated with Erlotinib
2022 · Saeedeh Shahriari, Sharareh Seifi, et al. · Medical Journal of the Islamic Republic of Iran · 1
PDF
Untitled
2022 · Jafarian, Aliakbar, Imani, Farnad, et al. · Journal of Medicinal and Chemical Sciences · 1
PDF
Authors′ reply
2012 · Shahin Shadnia, Kambiz Soltaninejad, et al. · Indian Journal of Critical Care Medicine · 1
PDF
Clinical Significance of Rheumatologic Autoantibodies in Treatment-Naïve Patients with Lymphoma, Breast, and Gastrointestinal Cancers: A Case-Control Study
2026 · Amirhossein Gholamlou, Nastaran Khodakarim, et al. · International Journal of Hematology-Oncology and Stem Cell Research
Deregulation of stemness and senescence genes in bone marrow mesenchymal stem cells of multiple myeloma: implications for therapeutic approaches
2026 · Fatemeh Soleymani, Saeideh Kavousi, et al. · Blood Research
Heterogeneous Response After [177Lu]Lu-FAPI-2286 Combination Therapy in Metastatic Breast Cancer
2026 · Ghasemali Divband, Masoume Chehrara, et al. · Clinical Nuclear Medicine
Successful treatment of an MBTPS2-linked Olmsted syndrome patient using erlotinib
2025 · Afsaneh Sadeghzadeh-Bazargan, Nastaran Khodakarim, et al. · JAAD Case Reports
Successful Treatment of Facial Pseudolymphoma With Intravenous Rituximab: A Case Report
2025 · Elham Behrangi, Nastaran Khodakarim, et al. · Clinical Case Reports
PDF
Works count: 33
Citation count: 416
H-index: 8
I10-index: 7
Year
Topic
Type